BGHC - BMO Global Health Care Fund Active ETF (CAD) (CA09662C1032)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout

Enregistrer Fermer

(%)

CA09662C1032

BGHC ISIN

Fonds négociés en bourse (FNB)

Type de fonds

BMO Global Asset Management

Fournisseur

20,35 CAD

valeur liquidative par action | 02/07/2026

26/06/2023

Date de lancement

1 fois par an

Paiement de dividendes

CEOJLU

CFI

BGHC

Ticker

Formed

Status

Equity

Objet d'investissement

Healthcare

Secteur

Global

Géographie

No benchmark

Benchmark

1.02 %

Ratio de coût total

Physical

Méthode de réplication

0,95 mln CAD

Actif total du fonds | 02/12/2025

Non

UCITS

Dernières données pour

Ajouter à comparer

Cotations (BGHC)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

175 910

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

Screener d'obligations
liste de surveillance
Excel ADD-IN

Obtenir l'accès

Dynamique des prix

Fund profile

The BMO Global Health Care Fund Active ETF is an actively managed ETF that seeks capital apprecaition by investing in a portfolio comprised primarily of global healthcare companies that exhibit growth characteristics

BGHC profile

The BMO Global Health Care Fund Active ETF (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The BMO Global Asset Management fund’s base currency is CAD and the share class was registered 26.06.2023 with unique ISIN - CA09662C1032. Main exchange is Cboe Canada and ticker symbol is BGHC. The total expense ratio is 1.02%. The BMO Global Health Care Fund Active ETF (CAD) pays dividends 1 time(s) per year.

Structure BGHC au 29/05/2026

Exporter la structure dans Excel

Titre	Valeur
Eli Lilly and Company	11,21%
UnitedHealth Group Incorporated	6,92%
Johnson & Johnson	6,72%
Merck & Co., Inc. Com	6,13%
Astrazeneca PLC Shs	5,93%
AbbVie Inc.	5,18%
ARGENX SE	4,37%
NOVARTIS AG	3,8%
Gilead Sciences, Inc.	3,56%
Cash	3,07%
BrightSpring Health Services, Inc.	3%
Roche Holdings AG	2,81%
Edwards Lifesciences Corporation	2,61%
GALDERMA GROUP AG	2,54%
McKesson Corporation	2,47%
Vertex Pharmaceuticals Incorporated	2,42%
Thermo Fisher Scientific Inc.	2,4%
Intuitive Surgical, Inc.	2,25%
Abbott Laboratories	2,14%
DexCom, Inc.	1,91%
IQVIA Holdings Inc.	1,86%
Stryker Corporation	1,72%
Cogent Biosciences, Inc.	1,53%
Cardinal Health, Inc.	1,43%
SARTORIUS STEDIM BIOTECH	1,26%
Crescent Biopharma, Inc.	1,11%
CVS Health Corporation	0,99%
The Cigna Group	0,97%
UCB SA	0,95%
Repligen Corporation	0,95%
iShares MSCI South Africa ETF	0,91%
Boston Scientific Corporation	0,87%
Regeneron Pharmaceuticals, Inc.	0,86%
Zimmer Biomet Holdings, Inc.	0,84%
Globus Medical, Inc.	0,83%
Royalty Pharma plc	0,71%
Savara Inc.	0,47%
SANOFI SA	0,3%

Montrer tout Cacher

Autres - %

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

{{ item.etf.ttl }}

{{ item.nav_usd }} mln
Valeur nette d'actifs

{{ item.expense_ratio }}
Ratio de coût total